Hikal Ltd (BOM:524735)
₹ 366.6 29.75 (8.83%) Market Cap: 45.20 Bil Enterprise Value: 53.03 Bil PE Ratio: 65.00 PB Ratio: 3.81 GF Score: 75/100

Q4 2022 Hikal Ltd Earnings Call Transcript

Jun 03, 2022 / 09:30AM GMT
Release Date Price: ₹292.8 (-7.65%)
Operator

Good day, and welcome to the Hikal Limited Q4 FY22 earnings conference call. This conference call may contain forward-looking statements about the company, which are based on the beliefs, opinions, and expectations of the company as on date of this call. these statements are not guarantees of future performance and involve risks and uncertainties that are difficult to predict. (Operator Instructions) Please note that this conference is being recorded.

I now hand the conference over to Mr. Anish Swadi, Business Transformation. Thank you, and over to you, sir.

Anish Swadi
Hikal Ltd. - Senior President - Animal Health & Business Transformation

Thank you, ladies and gentlemen, a very good afternoon to all of you, and thank you very much for joining us today for our Q4 2022 FY earnings call. I am Anish Swadi, Senior President of Business Transformation and Head of the Management Committee. With me, I have Mr. Kuldeep Jain, our Chief Financial Officer, Mr. Manoj Mehrotra, our President, Pharmaceuticals Business, Mr. Vimal Kulshrestha, President, Crop

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot